Rodney Scott

Professor Rodney Scott is a leading geneticist at the School of Biomedical Sciences and Pharmacy, University of Newcastle, Australia. He co-directs the Centre for Bioinformatics, Biomarker Discovery and Information-Based Medicine, pioneering interdisciplinary research linking bioinformatics with clinical practice to advance personalized medicine. His career spans over 20 years in hereditary cancer research, with global recognition in breast cancer, colorectal cancer, and Lynch syndrome genetics.

• Education: Privat Dozent (German DSc equivalent), University of Basel; PhD and BSc (Honours), University of Western Australia.

Scott’s research focuses on the genetic basis of malignancy, including modifier genes in disease penetrance, epigenetics in multiple sclerosis, and DNA repair mechanisms. His work bridges clinical genetics, bioinformatics, and pharmacogenomics, with recent studies on epigenetic signatures for disease progression and machine learning applications in genomic data analysis.

His 15 most recent articles highlight trends in genomic risk modeling, epigenetics, environmental-cancer interactions, and pharmacogenomic testing. Key areas include endometrial and colorectal cancer susceptibility loci, DPYD-guided chemotherapy, and multi-omics approaches to multiple sclerosis and schizophrenia.

• Scientific Awards: Fellow of the Royal Society of NSW (2017); Honorary PhD from Pomeranian Academy of Medicine (2017); FRCPath (2005); Fellow of Royal College of Pathologists of Australasia (2011).

Scott has supervised numerous PhD students and contributes to national committees on genetic services and bioethics. He collaborates extensively with the Hunter Medical Research Institute and international institutions, integrating genomic and clinical data for translational impact.